• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过氢磁共振波谱法(H-MRS)检测肝内脂肪酸组成作为非酒精性脂肪性肝病(NAFLD)从单纯性脂肪肝进展为非酒精性脂肪性肝炎(NASH)的生物标志物。

Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using H-MRS.

作者信息

Xavier Aline, Zacconi Flavia, Gainza Constanza, Cabrera Daniel, Arrese Marco, Uribe Sergio, Sing-Long Carlos, Andia Marcelo E

机构信息

Biomedical Imaging Center, Pontificia Universidad Católica de Chile Chile

Millennium Nucleus for Cardiovascular Magnetic Resonance Chile.

出版信息

RSC Adv. 2019 Dec 19;9(72):42132-42139. doi: 10.1039/c9ra08914d. eCollection 2019 Dec 18.

DOI:10.1039/c9ra08914d
PMID:35542850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9076551/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world and it is becoming one of the most frequent cause of liver transplantation. Unfortunately, the only available method that can reliably determine the stage of this disease is liver biopsy, however, it is invasive and risky for patients. The purpose of this study is to investigate changes in the intracellular composition of the liver fatty acids during the progression of the NAFLD in a mouse model fed with Western diet, with the aim of identify non-invasive biomarkers of NAFLD progression based in H-MRS. Our results showed that the intracellular liver fatty acid composition changes as NAFLD progresses from simple steatosis to steatohepatitis (NASH). Using principal component analysis with a clustering method, it was possible to identify the three most relevant clinical groups: normal, steatosis and NASH by using H-MRS. These results showed a good agreement with the results obtained by GC-MS and histology. Our results suggest that it would be possible to detect the progression of simple steatosis to NASH using H-MRS, that has the potential to be used routinely in clinical application for screening high-risk patients.

摘要

非酒精性脂肪性肝病(NAFLD)是全球最常见的肝脏疾病,并且正成为肝移植最常见的病因之一。不幸的是,唯一能够可靠确定该疾病阶段的方法是肝活检,然而,这对患者具有侵入性且有风险。本研究的目的是在喂食西方饮食的小鼠模型中,研究NAFLD进展过程中肝脏脂肪酸细胞内组成的变化,旨在基于氢磁共振波谱(H-MRS)识别NAFLD进展的非侵入性生物标志物。我们的结果表明,随着NAFLD从单纯性脂肪变性进展为脂肪性肝炎(NASH),肝脏脂肪酸的细胞内组成会发生变化。使用主成分分析和聚类方法,通过H-MRS能够识别出三个最相关的临床组:正常、脂肪变性和NASH。这些结果与通过气相色谱-质谱联用仪(GC-MS)和组织学获得的结果高度一致。我们的结果表明,使用H-MRS有可能检测到单纯性脂肪变性向NASH的进展,其有潜力在临床应用中常规用于筛查高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/1692d6ad0a4c/c9ra08914d-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/e7d5b134a326/c9ra08914d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/e33dacc668cf/c9ra08914d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/0381edb56465/c9ra08914d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/036e20064452/c9ra08914d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/7d30d1700d52/c9ra08914d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/91e24d4e744f/c9ra08914d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/ad5c357bca7a/c9ra08914d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/d05ec0162366/c9ra08914d-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/f37f6da8a438/c9ra08914d-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/1692d6ad0a4c/c9ra08914d-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/e7d5b134a326/c9ra08914d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/e33dacc668cf/c9ra08914d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/0381edb56465/c9ra08914d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/036e20064452/c9ra08914d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/7d30d1700d52/c9ra08914d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/91e24d4e744f/c9ra08914d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/ad5c357bca7a/c9ra08914d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/d05ec0162366/c9ra08914d-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/f37f6da8a438/c9ra08914d-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7843/9076551/1692d6ad0a4c/c9ra08914d-f10.jpg

相似文献

1
Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using H-MRS.通过氢磁共振波谱法(H-MRS)检测肝内脂肪酸组成作为非酒精性脂肪性肝病(NAFLD)从单纯性脂肪肝进展为非酒精性脂肪性肝炎(NASH)的生物标志物。
RSC Adv. 2019 Dec 19;9(72):42132-42139. doi: 10.1039/c9ra08914d. eCollection 2019 Dec 18.
2
Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy.使用磁共振波谱评估非酒精性脂肪性肝炎进展过程中的肝内脂肪酸。
Ann Hepatol. 2021 Nov-Dec;25:100358. doi: 10.1016/j.aohep.2021.100358. Epub 2021 May 4.
3
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.非酒精性脂肪性肝病全谱的代谢特征
JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
4
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.超高场磁共振波谱在非酒精性脂肪性肝病中的应用:非酒精性脂肪性肝炎和肝纤维化能量代谢的新机制和诊断见解。
Liver Int. 2017 Oct;37(10):1544-1553. doi: 10.1111/liv.13451. Epub 2017 May 20.
5
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
6
Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.严重肥胖症中的肝脂质组学重塑表现为脂肪变性,且不会随着非酒精性脂肪性肝炎而进展。
J Hepatol. 2021 Sep;75(3):524-535. doi: 10.1016/j.jhep.2021.04.013. Epub 2021 Apr 20.
7
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.
8
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.脂肪肝进展算法和脂肪变性、活动度及纤维化评分在评估非酒精性脂肪肝对未经治疗的慢性乙型肝炎患者影响中的应用。
Front Cell Infect Microbiol. 2022 Jan 17;11:733348. doi: 10.3389/fcimb.2021.733348. eCollection 2021.
9
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.巨噬细胞衍生的血小板反应蛋白1促进肥胖相关的非酒精性脂肪性肝病。
JHEP Rep. 2020 Oct 9;3(1):100193. doi: 10.1016/j.jhepr.2020.100193. eCollection 2021 Feb.
10
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.非酒精性脂肪性肝病 (NAFLD) 的诊断:现状。
Curr Pharm Des. 2018;24(38):4574-4586. doi: 10.2174/1381612825666190117102111.

引用本文的文献

1
Liver magnetic resonance spectroscopy as an alternative for evaluating Niemann-Pick C disease progression.肝脏磁共振波谱分析作为评估尼曼-匹克C型病进展的一种替代方法。
RSC Adv. 2025 Feb 6;15(6):4079-4085. doi: 10.1039/d4ra06781a.
2
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.采用磁共振波谱技术对肝脏脂肪酸进行特征分析,以评估内皮型一氧化氮合酶(eNOS)小鼠代谢性非酒精性脂肪性肝病/非酒精性脂肪性肝炎模型中二甲双胍治疗反应。
NMR Biomed. 2023 Aug;36(8):e4932. doi: 10.1002/nbm.4932. Epub 2023 Apr 11.
3

本文引用的文献

1
Mechanisms of NAFLD development and therapeutic strategies.非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
2
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.穿心莲内酯可改善实验性非酒精性脂肪性肝炎中的炎症和纤维化,并减弱炎症小体的激活。
Sci Rep. 2017 Jun 14;7(1):3491. doi: 10.1038/s41598-017-03675-z.
3
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View.
ω-3 脂肪酸与橄榄油成分联合应用于非酒精性脂肪性肝病模型的临床前研究:一种机制观点。
Nutrients. 2020 Feb 15;12(2):499. doi: 10.3390/nu12020499.
一项对纤维化非酒精性脂肪性肝炎小鼠模型进行的全身、组织和细胞生理学纵向研究,该模型高度逼真地模拟了人类病情。
Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G666-G680. doi: 10.1152/ajpgi.00213.2016. Epub 2017 Feb 23.
4
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
5
Non-alcoholic fatty liver disease in 2015.2015年的非酒精性脂肪性肝病
World J Hepatol. 2015 Jun 18;7(11):1450-9. doi: 10.4254/wjh.v7.i11.1450.
6
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.控释线粒体质子载体可逆转大鼠糖尿病和脂肪性肝炎。
Science. 2015 Mar 13;347(6227):1253-6. doi: 10.1126/science.aaa0672. Epub 2015 Feb 26.
7
Biomarkers in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的生物标志物。
Can J Gastroenterol Hepatol. 2014 Dec;28(11):607-18. doi: 10.1155/2014/757929.
8
Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝脏脂肪酸组成特征。
Liver Int. 2015 Feb;35(2):582-90. doi: 10.1111/liv.12685. Epub 2014 Oct 10.
9
Quantification of the triglyceride fatty acid composition with 3.0 T MRI.使用3.0 T磁共振成像对甘油三酯脂肪酸组成进行定量分析。
NMR Biomed. 2014 Oct;27(10):1211-21. doi: 10.1002/nbm.3175. Epub 2014 Aug 14.
10
Streptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in mice.链脲佐菌素诱导的糖尿病部分减弱了高脂饮食对小鼠肝脏和脑脂肪酸组成的影响。
Lipids. 2013 Sep;48(9):939-48. doi: 10.1007/s11745-013-3817-z. Epub 2013 Jul 28.